DM - Complications Flashcards

1
Q

For every 1% decrease in HbA, there is a ___% decrease in mortality and ____% decrease in microvascular complications

A

21%, 37%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1 cause of chronic kidney disease (CKD),

ESRD, & CKD requiring renal replacement
therapy (aka Dialysis)

A

Diabetic Nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most common cause of Nephrotic Syndrome

A

40% of DM II
30% of DM I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Nephrotic Syndrome

A
  • Loss of protein from plasma into urine
    2° ↑ glomerular permeability
  • Leads to generalized edema,
    hypoalbuminemia, hyperlipidemia, &
    frank proteinuria (detectable with urine
    dipstick)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Etiology/Pathogenesis of Diabetic nephropathy

A

Glomerular Damage

leaking protein into urine

Hypoalbuminemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypoalbuminemia process

A

↓osmotic pressure
↑ edema
↓ vascular volume
↓ blood pressure
↑ kidney renin production
↑ aldosterone
↑ sodium & water retention
↑ intravascular fluid
↑ edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

40% of patients with diabetes develop diabetic ____

A

nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F Smoking accelerates the decline in renal function

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Annual assessments for Diabetic nephropathy

A
  • Serum Creatinine (Cr) to determine eGFR
  • Urine Albumin & Cr to determine
    Albumin/Cr ratio
  • Begin annual screening 5 years after diagnosis of DM I or At diagnosis of DM II or DM I
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When Management of Diabetic Nephropathy requires Nephrologist referral

A

✅ Atypical presentation
✅ Rapid decline in eGFR OR albuminuria progression
✅ Stage 4 CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management of Diabetic Nephropathy

A
  1. Smoking cessation
  2. RAAS blockade for albuminuria
  3. Nephrologist referral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1 cause of preventable blindness in adults

A

Diabetic Retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Epidemiology of Diabetic Retinopathy

A
  • 86% of DM I
  • 40% of DM II
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk Factors of Diabetic Retinopathy

A
  • African-American, Hispanic, South Asian
  • ↓ age at Dx of DM
  • HTN
  • Dyslipidemia
  • Pregnancy
  • Puberty
  • Cataract surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical Presentation of Diabetic Retinopathy

A
  • *Often Asymptomatic!
  • Blurred or double vision
  • ↓ field of vision
  • Seeing dark spots
  • Pressure or pain in eyes
  • ↓ vision in dim light
  • Sudden blindness (rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical features on funduscopic exam vary by disease severity

A
  • Neovascularization
  • Ischemia
  • Microaneurysms: Earliest clinical sign
17
Q

Diabetic Neuropathy in multiple systems

A
  • Cardiovascular → resting tachycardia & orthostatic hypotension
  • Genitourinary → Gastroparesis & bladder-emptying abnormalities
  • Skin → Hyperhidrosis of the upper extremities & anhidrosis of the lower
    extremities result from sympathetic nervous system dysfunction
    Anhidrosis of the feet → dry skin → cracking → ↑ risk of foot ulcers
  • Endocrine → Autonomic neuropathy may ↓ counter-regulatory
    hormone release (esp. catecholamines) → ↓ sensation of hypoglycemia
18
Q

Assessment of Diabetic Neuropathy

A

Begin assessment
5 years after diagnosis of DM I
At diagnosis of DM II

Complete neurologic examination
annually
Assess for Heart Rate Variability
Deep inspiration
Valsalva maneuver
Change in position from supine
to standing

19
Q

FDA approved for Diabetic Neuropathy

A

duloxetine (Cymbalta®)
amitriptyline (Elavil®)
pregabalin (Lyrica®)
Capsaicin 8% patch

20
Q

Management of Large-fiber neuropathies

A

↓ joint position, vibration sensation & sensory ataxia

21
Q

Management of Small-fiber neuropathies

A

↓ pain, temperature & autonomic function

22
Q

Treatment of Diabetic Neuropathy

A

Improved glycemic control
Hydrate
Chew your food
Small meals low in fat/fiber
Prevent bezoar
Liquid nutritional supplements
E.g. Glucerna®
Otherwise tx are inadequate

23
Q

____ Study showed ↑ in PAD, CAD, MI, & CHF

A

Framingham Heart

24
Q

American Heart Association has designated DM as a
“_______” & DM II patients without a prior MI
have a similar risk for coronary artery–related events as nondiabetic individuals who have had a prior MI.

A

CHD risk equivalent

25
Q

DM is the ___ cause of nontraumatic lower
extremity amputation in the US

A

1

26
Q

___% of all lower limb amputations in patients with DM are preceded by a foot ulcer

A

85

27
Q

Management of lower extremity complications in DM patients

A

Educate high-risk patients on ulcer prevention, every visit
Screen for asymptomatic PAD

28
Q

↓ risk factors for vascular disease in Lower extremity complications of DM patients

A

Smoking cessation
Dyslipidemia
Hypertension
Tight glycemic control

29
Q

When to refer lower extremity complications to Podiatry

A

Protracted wound healing & skin
ulceration
Callus deformities
Nail deformities
Annual Exam
Orthotic shoes, inserts, & devices
Education about off the shelf
footwear

30
Q

Most common skin manifestations of DM are

A

Xerosis and Pruritus

31
Q

DERMATOLOGIC MANIFESTATIONS in DM

A

Bullosa Diabeticorum: DM related bullae
Vitiligo: ↑ frequency in T1 DM
Acanthosis Nigricans: Hyperpigmented velvety plaques, signals severe insulin resistance
Lipoatrophy & lipohypertrophy: insulin injection sites

32
Q
A